The treatment approach for type 2 diabetes mellitus includes several conventional therapies, namely miglitol and acarbose, which delay the absorption of carbohydrates from food intake, sulfonylureas, which enhance insulin secretion, troglitazone, which increases insulin action in fat and muscle and metformin, which enhances the insulin mechanism in liver tissues [9,10,11,12]. This evidence concerns the gene INS and diabetes mellitus.